Suboxone.com - Webinars

The requested information is provided in Portable Document Format (PDF). To view and print this document you'll need to install a copy of the free Adobe® Acrobat® Reader®. If you already have Adobe Acrobat Reader installed click "View PDF" below. If you need the Acrobat Reader you can download it from the Adobe Acrobat Reader Download page.

You are leaving Suboxone.com. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Clicking on "Continue" will take you to a website that is outside the control of Reckitt Benckiser Pharmaceuticals. You are solely responsible for your interactions with such websites.

Links are provided as a public service and for informational purposes only.

IMPORTANT INFORMATION:

On December 8, 2006, Federal legislation was passed allowing physicians to treat up to 100 opioid dependent patients with Suboxone at any given time—a significant increase from the previous limit of 30 patients.

If you can read this, then your browser cannot interpret Javascript. To take full advantage of what this website has to offer, please make sure that you have Javascript enabled in your browser preferences, or update to a browser that supports Javascript. Thank you.

Prescribing Information -- Site Map

SUBOXONE Webinars

Video presentations addressing the most common questions healthcare professionals have when starting to prescribe SUBOXONE

SUBOXONE Practice Management Tool Kit

Information about treating opioid dependence, including patient management, preparing your practice, creating a referral network, and more.

Webinars

The Suboxone Webinar Series was created to assist healthcare professionals in treating opioid dependence in a private office setting. Experienced professionals from the psychiatry, primary care and nursing fields share their insights as well as practical advice for successfully integrating SUBOXONE into your practice.

Each video is easily navigable and accompanied by key point slides and useful tools related to the topics being discussed.

PSYCHIATRY

Dr. Samuel M. Silverman F.A.P.A
Samuel M. Silverman, F.A.P.A., is the medical director of Substance Abuse Services at Rushford Behavioral Health in Glastonbury, Connecticut.

PRIMARY CARE

Mark L. Kraus, M.D., FASAM
Dr. Kraus is a general internist in private practice and the Medical Director of Addiction Medicine at Waterbury Hospital, Waterbury, Connecticut.

NURSING

Kathleen Thompson-Gargano, RN, ADN, CNIII
Kathleen Thompson-Gargano is Vice President and Co-founder of the National Alliance of Advocates for Buprenorphine Treatment (NAABT). Kathleen is from the Yale Buprenorphine and Addiction Research center in Connecticut.